Plus Therapeutics (PSTV) News Today → AI's Next Magnificent Seven (From The Oxford Club) (Ad) Free PSTV Stock Alerts $2.35 -0.13 (-5.24%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 7:30 AM | globenewswire.comPlus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRITMay 18, 2024 | finanznachrichten.dePlus Therapeutics Inc.: Plus Therapeutics Announces New Employment Inducement GrantsMay 17, 2024 | globenewswire.comPlus Therapeutics Announces New Employment Inducement GrantsMay 16, 2024 | msn.comPlus Therapeutics, Inc. (NASDAQ:PSTV) Q1 2024 Earnings Call TranscriptMay 16, 2024 | finance.yahoo.comPlus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...May 15, 2024 | sfgate.comPlus: Q1 Earnings SnapshotMay 15, 2024 | markets.businessinsider.comPlus Therapeutics Inc. Q1 Loss Decreases, Beats EstimatesMay 15, 2024 | globenewswire.comPlus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 13, 2024 | globenewswire.comPlus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024May 12, 2024 | uk.investing.comPlus Therapeutics CEO buys $25,000 in company stockMay 11, 2024 | insidertrades.comAndrew John Hugh Macintyr Sims Acquires 4,902 Shares of Plus Therapeutics, Inc. (NASDAQ:PSTV) StockMay 10, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Plus Therapeutics (PSTV) and Argenx Se (ARGX)May 9, 2024 | globenewswire.comPlus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE TrialMay 8, 2024 | globenewswire.comPlus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE TrialApril 22, 2024 | finance.yahoo.comMicro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of DefenseApril 22, 2024 | globenewswire.comPlus Therapeutics Receives $3 Million Award Recommendation from the United States Department of DefenseApril 19, 2024 | finance.yahoo.comPlus Therapeutics, Inc. (PSTV)April 9, 2024 | finance.yahoo.comNeuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management TeamApril 9, 2024 | globenewswire.comNeuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D.March 27, 2024 | finance.yahoo.comPlus Therapeutics to Present at the National Comprehensive Cancer Network Annual ConferenceMarch 25, 2024 | finance.yahoo.comPlus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell DiagnosticMarch 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for Plus Therapeutics Amidst Clinical Advancements and Industry TailwindsMarch 11, 2024 | finance.yahoo.comPlus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal MetastasesMarch 7, 2024 | finance.yahoo.comPlus Therapeutics Full Year 2023 Earnings: Beats ExpectationsMarch 7, 2024 | finance.yahoo.comPlus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call TranscriptMarch 6, 2024 | finance.yahoo.comQ4 2023 Plus Therapeutics Inc Earnings CallMarch 5, 2024 | investorplace.comPSTV Stock Earnings: Plus Therapeutics Beats EPS, Beats Revenue for Q4 2023March 5, 2024 | globenewswire.comPlus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business HighlightsFebruary 29, 2024 | msn.comIMUNON stock rallies 19% on early results for COVID-19 vaccineFebruary 27, 2024 | finance.yahoo.comPlus Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on March 5, 2024February 21, 2024 | morningstar.comPlus Therapeutics Inc PSTVDecember 18, 2023 | finanznachrichten.dePlus Therapeutics Inc.: Plus Updates Financial and Cash Guidance for 2024December 18, 2023 | finance.yahoo.comPlus Updates Financial and Cash Guidance for 2024December 12, 2023 | finance.yahoo.comPlus Therapeutics Partners With K2bio for Development of Novel Tests for Cerebrospinal Fluid (CSF) Tumor Cell and Molecular Biomarker AnalysesNovember 29, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Halozyme (HALO), HUTCHMED (HCM) and Plus Therapeutics (PSTV)November 20, 2023 | msn.comFortress Biotech, Plus Therapeutics among healthcare moversNovember 20, 2023 | finance.yahoo.comPlus Therapeutics Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader WebinarNovember 15, 2023 | finance.yahoo.comPlus Therapeutics to Host Virtual KOL Event on New Phase 2 ReSPECT-GBM Data in Recurrent Glioblastoma Presented at the Society for NeuroOncology (SNO) Conference on Monday, November 20, 2023November 3, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Geron (GERN), Silk Road Medical (SILK) and Plus Therapeutics (PSTV)November 3, 2023 | finance.yahoo.comPlus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal MetastasesNovember 1, 2023 | benzinga.comWhy Plus Therapeutics Stock Popped TodayNovember 1, 2023 | finanznachrichten.dePlus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business HighlightsOctober 31, 2023 | finance.yahoo.comPlus Therapeutics Reports Third Quarter 2023 Financial Results and Business HighlightsOctober 25, 2023 | finance.yahoo.comPlus Therapeutics to Present at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader WebinarOctober 23, 2023 | finance.yahoo.comPlus Therapeutics to Announce Third Quarter 2023 Financial Results and Host Conference Call on October 31, 2023October 9, 2023 | finance.yahoo.comPlus Therapeutics to Participate in the Jones Trading Healthcare Summit and ThinkEquity Conference in OctoberSeptember 19, 2023 | finance.yahoo.comTargeted Cancer Treatment: Plus Therapeutics CEO Marc Hedrick, Live from NYSESeptember 15, 2023 | finance.yahoo.comDirector Howard Clowes Buys 6,993 Shares of Plus Therapeutics IncSeptember 11, 2023 | markets.businessinsider.comJonesTrading Sticks to Its Buy Rating for Plus Therapeutics (PSTV)September 11, 2023 | msn.comPlus Therapeutics gets $1.9M advance payment from CPRIT Get Plus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. PSTV Media Mentions By Week PSTV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSTV News Sentiment▼0.000.77▲Average Medical News Sentiment PSTV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSTV Articles This Week▼11▲PSTV Articles Average Week Get Plus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PSTV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Apyx Medical News Today Neuronetics News Today SEP Acquisition News Today Carmell News Today LENSAR News Today Cytosorbents News Today Lucid Diagnostics News Today IceCure Medical News Today Beyond Air News Today DarioHealth News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PSTV) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored